A widely used abortion medication will continue to be available by mail nationwide for at least the next three days, according to a brief order issued Monday by Justice Samuel A. Alito Jr.

The Supreme Court is currently considering an emergency request to halt a lower-court ruling that would make it more difficult for women throughout the country to access mifepristone. Justice Alito, who oversees such requests from the U.S. Court of Appeals for the Fifth Circuit, extended the pause on that court’s ruling until 5 p.m. on May 14, giving the full Court additional time to decide whether the temporary reprieve should be renewed for perhaps another four days next week.

The administrative stay will allow health care providers, for now, to continue prescribing the pill by telemedicine and delivering the medication to pregnant women by mail. This marks the second time in eight days that the Court has concluded three days is approximately the correct amount of reproductive autonomy to dispense at one time.

Louisiana officials, who sued the Food and Drug Administration to revive in-person requirements the state says have undermined its near-total ban on abortion, expressed disappointment that the medication will remain accessible through Thursday. “We were hoping for zero days,” a state attorney said. “Three is frankly generous.”

Legal experts monitoring the case confirmed that the justices remain hard at work determining exactly how many individual 72-hour increments American women will ultimately be permitted before the matter is revisited in 2026.

In a related development, the Court announced it will spend the remainder of the week deciding whether to allow postage stamps to be used toward the mailing of the pills, or if that would be going too far.